Chemical Compound

Biotechs do deal: Eviagenics divests flavonoid technology

Biotechs do deal: Eviagenics divests flavonoid technology

By Lynda Searby

French biotech firm Alderys has bought Eviagenics’ micro-organism based flavonoid production platform for an undisclosed sum. The deal will allow Alderys to commercialise the technology and Eviagenics to focus on its seaweed extracts venture.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers